| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease
|
Roberts, Peter J.
|
|
2002
|
38 |
S5 |
p. S37-S38
2 p.
|
article
|
| 2 |
Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571)
|
Demetri, George D.
|
|
2002
|
38 |
S5 |
p. S52-S59
8 p.
|
article
|
| 3 |
Imatinib and chronic myeloid leukemia: validating the promise of molecularly targeted therapy
|
Druker, Brian J.
|
|
2002
|
38 |
S5 |
p. S70-S76
7 p.
|
article
|
| 4 |
Imatinib: a selective tyrosine kinase inhibitor
|
Manley, P.W.
|
|
2002
|
38 |
S5 |
p. S19-S27
9 p.
|
article
|
| 5 |
Imatinib: the first 3 years
|
Capdeville, Renaud
|
|
2002
|
38 |
S5 |
p. S77-S82
6 p.
|
article
|
| 6 |
Introduction
|
Joensuu, H.
|
|
2002
|
38 |
S5 |
p. S1-
1 p.
|
article
|
| 7 |
Overview of issues related to imatinib therapy of advanced gastrointestinal stromal tumors: a discussion among the experts
|
Silbermann, Sandra
|
|
2002
|
38 |
S5 |
p. S66-S69
4 p.
|
article
|
| 8 |
Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review
|
Miettinen, Markku
|
|
2002
|
38 |
S5 |
p. S39-S51
13 p.
|
article
|
| 9 |
Pharmacology of imatinib (STI571)
|
Buchdunger, Elisabeth
|
|
2002
|
38 |
S5 |
p. S28-S36
9 p.
|
article
|
| 10 |
Regulation and targets of receptor tyrosine kinases
|
Pawson, Tony
|
|
2002
|
38 |
S5 |
p. S3-S10
8 p.
|
article
|
| 11 |
Significance of tyrosine kinases in cancer: overview
|
Andersson, Leif C.
|
|
2002
|
38 |
S5 |
p. S2-
1 p.
|
article
|
| 12 |
Tyrosine kinases as targets for cancer therapy
|
Levitzki, Alexander
|
|
2002
|
38 |
S5 |
p. S11-S18
8 p.
|
article
|
| 13 |
Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group
|
van Oosterom, Allan T.
|
|
2002
|
38 |
S5 |
p. S83-S87
5 p.
|
article
|
| 14 |
Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs)
|
Van den Abbeele, Annick D.
|
|
2002
|
38 |
S5 |
p. S60-S65
6 p.
|
article
|
Journal description